ArticleMelanoma research2017

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland.

Joanna Mangana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.